FTLD-TDP and progressive supranuclear palsy in comorbidity—a report of two cases with different clinical presentations

References

• Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., & Schneider, L. S.; AL-108-231 Investigators. (2014). Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurology, 13, 676–685. doi:10.1016/S1474-4422(14)70088-2
   PubMed Web of Science ®Google Scholar
• Clippinger, A. K., D’Alton, S., Lin, W. L., Gendron, T. F., Howard, J., Borchelt, D. R., Lewis, J. (2013). Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica, 126, 39–50. doi:10.1007/s00401-013-1123-8
   PubMed Web of Science ®Google Scholar
• Iwasaki, Y., Mori, K., Ito, M., Tatsumi, S., Mimuro, M., & Yoshida, M. (2013). An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement. Neuropathology, 33, 561–567. doi:10.1111/neup.12012
   PubMed Web of Science ®Google Scholar
• Josephs, K. A., Whitwell, J. L., Boeve, B. F., Shiung, M. M., Gunter, J. L., Parisi, J. E., Jack, C. R. (2006). Rates of cerebral atrophy in autopsy-confirmed progressive supranuclear palsy. Annals of Neurology, 59, 200–203. doi:10.1002/ana.20707
   PubMed Web of Science ®Google Scholar
• Kanazawa, M., Tada, M., Onodera, O., Takahashi, H., Nishizawa, M., & Shimohata, T. (2013). Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Parkinsonism and Related Disorders, 19, 1149–1151. doi:10.1016/j.parkreldis.2013.07.019
   PubMed Web of Science ®Google Scholar
• Kertesz, A. (2003). Pick complex: An integrative approach to frontotemporal dementia: Primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. The Neurologist, 9, 311–317. doi:10.1097/01.nrl.0000094943.84390.cf
   PubMed Web of Science ®Google Scholar
• Kertesz, A., Finger, E., Murrell, J., Chertkow, H., Ang, L. C., Baker, M., Munoz, D. G. (2015). Progressive supranuclear palsy in a family with TDP-43 pathology. Neurocase, 21, 178–184. doi:10.1080/13554794.2013.878729
   PubMed Web of Science ®Google Scholar
• Kobylecki, C., Jones, M., Thompson, J. C., Richardson, A. M., Neary, D., Mann, D. M., Gerhard, A. (2015). Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. Journal of Neurology, 262, 916–922. doi:10.1007/s00415-015-7657-z
   PubMed Web of Science ®Google Scholar
• Koga, S., Josephs, K. A., Ogaki, K., Labbé, C., Uitti, R. J., Graff-Radford, N., & Dickson, D. W. (2016). Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C. Movement Disorders, 31, 653–662. doi:10.1002/mds.26499
   PubMed Web of Science ®Google Scholar
• Kouri, N., Oshima, K., Takahashi, M., Murray, M. E., Ahmed, Z., Parisi, J. E., Dickson, W. (2013). Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: An unusual clinicopathologic variant of CBD. Acta Neuropathologica, 125, 741–752. doi:10.1007/s00401-013-1087-8
   PubMed Web of Science ®Google Scholar
• Onyike, C. U., & Diehl-Schmid, J. (2013). The epidemiology of frontotemporal dementia. International Review of Psychiatry, 25, 130–137. doi:10.3109/09540261.2013.776949
   PubMed Web of Science ®Google Scholar
• Pick, A. (1892). Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager Medicinische Wochenschrift, 17, 165–167.
   Google Scholar
• Pick, A. (1904a). Über primäre progressive Demenz bei Erwachsenen. Prager Medizinische Wochenschrift, 29, 417–419.
   Google Scholar
• Pick, A. (1904b). Zur Symptomatologie der linksseitigen Schläfenlappenatrophie. Monatsschrift für Psychiatrie und Neurologie, 16, 378–388. doi:10.1159/000219215
   Google Scholar
• Pick, A., Girling, D. M., & Berrios, G. E. (1994). On the relationship between senile cerebral atrophy and aphasia. History of Psychiatry, 5, 542–547. doi:10.1177/0957154X9400502007
   Google Scholar
• Pick, A., Girling, D. M., & Berrios, G. E. (1997). On the symptomatology of left-sided temporal lobe atrophy. History of Psychiatry, 8, 149–159. doi:10.1177/0957154X9700802910
   PubMed Web of Science ®Google Scholar
• Riedl, L., Mackenzie, I. R., Förstl, H., Kurz, A., & Diehl-Schmid, J. (2014). Frontotemporal lobar degeneration: Current perspectives. Neuropsychiatric Disease and Treatment, 10, 297–310. doi:10.2147/NDT.S38706
   PubMed Web of Science ®Google Scholar
• Rippon, G. A., Boeve, B. F., Parisi, J. E., Dickson, D. W., Ivnik, R. I., Jack, C. R., Petersen, R. C. (2005). Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology. Neurocase, 11, 204–211. doi:10.1080/13554790590944753
   PubMed Web of Science ®Google Scholar
• Rohan, Z., & Matej, R. (2014). Current concepts in the classification and diagnosis of frontotemporal lobar degenerations: A practical approach. Archives of Pathology & Laboratory Medicine, 138, 132–138. doi:10.5858/arpa.2012-0510-RS
   PubMed Web of Science ®Google Scholar
• Sieben, A., Van Langenhove, T., Engelborghs, S., Martin, J. J., Boon, P., Cras, P., Cruts, M. (2012). The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathologica, 124, 353–372. doi:10.1007/s00401-012-1029-x
   PubMed Web of Science ®Google Scholar
• Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E., Johansen-Berg, H., & Matthews, P. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23, 208–219. doi:10.1016/j.neuroimage.2004.07.051
   PubMed Web of Science ®Google Scholar
• Smith, S. M., Zhang, Y., Jenkinson, M., Chen, J., Matthews, P. M., Federico, A., & De Stefano, N. (2002). Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage, 17, 479–489. doi:10.1006/nimg.2002.1040
   PubMed Web of Science ®Google Scholar
• Williams, D. R., Holton, J. L., Strand, C., Pittman, A., De Silva, R., Lees, A. J., & Revesz, T. (2007). Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson’s syndrome. Brain, 130, 1566–1576. doi:10.1093/brain/awm104
   PubMed Web of Science ®Google Scholar
• Yokota, O., Davidson, Y., Bigio, E. H., Ishizu, H., Terada, S., Arai, T., Mann, D. M. (2010). Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathologica, 120, 55–66. doi:10.1007/s00401-010-0731-9
   PubMed Web of Science ®Google Scholar